FREE Case Review (866) 588-0600

Zarah Lawsuit

sc-no-longer-accepting-cases

Women who take Zarah or other birth control products containing drospirenone face an increased risk of life-threatening injuries. Financial compensation may be available for women who have suffered from a heart attack, stroke or blood clot after taking Zarah. All cases are reviewed and investigated under a contingency fee, which means that clients of our Zarah lawyers pay no fees or expenses unless a recovery is obtained.

Zarah Blood Clot Update 4/10/12: Birth control products containing the synthetic hormone drospirenone have been linked to an increased risk for blood clots, according to a warning issued today by the U.S. Food & Drug Administration (FDA). In response to these findings, the FDA has required that all drospirenone-containing contraceptives carry warnings which state that several studies have found as much as a three-fold increased risk of blood clots associated with drospirenone when compared to levonorgestrel, a different hormone found in many older forms of birth control.

Zarah Blood Clot Update 12/9/11: An independent advisory panel to the FDA has recommended that all birth control products containing the hormone drospirenone should have their labels updated to include warnings about blood clots. The panel’s recommendation was based on new data suggesting that the popular contraceptives may put women at a higher risk for dangerous blood clots than older forms of birth control.

Zarah Background

Zarah is a generic version of the contraceptive Yasmin that is made by Watson Pharmaceuticals. It contains ethinyl estradiol and the new “fourth generation” progestin drospirenone. Zarah provides an oral birth control regimen consisting of 21 active tablets each containing 3 mg of drospirenone and 0.030 mg of ethinyl estradiol and 7 inert tablets.

Zarah Side Effects

The amount of drospirenone used in Zarah may seem small, yet is sufficient to cause serious side effects in high risk women. It can lead to the following conditions:

  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Venous Thromboembolism (VTE)
  • Pulmonary Embolism (PE)
  • Hyperkalemia
  • Stroke
  • Cerebrovascular Accidents (CVA)
  • Heart Attack
  • Myocardial Infarction
  • Gallbladder Disease / Injury (cholecystitis)
  • Gallbladder Removal (cholecystectomy)
  • Death

Two studies published in the British Medical Journal (BMJ) found that women using contraceptives that contain drospirenone were at a significantly increased risk of developing venous thromboembolism (VTE) than those taking one containing the progestogen levonorgestrel. The BMJ research concluded that the increased risk was 2-3 times greater in women taking these types of oral contraceptives. Many Zarah lawyers believe that these findings justify the claims of women filing lawsuits as a result of Zarah side effects.

Drospirenone Birth Control Pills

Since 2004, at least 50 deaths have been reported in women taking contraceptives made with drospirenone. No one knows how many more young women may have been affected by its side effects. If you or someone you love suffered a stroke, blood clot, heart attack or other side effect while using this drug, we want to hear from you. Please contact one of our Zarah side effects lawyers right away to protect your legal rights.

Zarah Oral Warnings

Do not use Zarah if you smoke cigarettes and are over 35 years old, as this combination raises your risk of stroke, heart attack, blood clots, and high blood pressure. The risk of these side effects increases with age and the number of cigarettes you smoke. Before using Zarah, tell your healthcare professional if you are allergic to ethinyl estradiol, drospirenone, or any other progestins. Additionally, Zarah may contain inactive ingredients which can cause allergic reactions and other problems.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition